A pilot study of nimotuzumab plus single agent chemotherapy as second- or third-line treatment or more in patients with recurrent, persistent or metastatic cervical cancer.
about
The safety and efficacy of bevacizumab in the treatment of patients with recurrent or metastatic cervical cancer.Investigational drugs for the treatment of cervical cancer.Safety and efficacy of nimotuzumab combined with chemoradiotherapy in Chinese patients with locally advanced cervical cancer.A prospective study on neoadjuvant chemoradiotherapy plus anti-EGFR monoclonal antibody followed by surgery for locally advanced cervical cancer.
P2860
A pilot study of nimotuzumab plus single agent chemotherapy as second- or third-line treatment or more in patients with recurrent, persistent or metastatic cervical cancer.
description
2015 nî lūn-bûn
@nan
2015年の論文
@ja
2015年論文
@yue
2015年論文
@zh-hant
2015年論文
@zh-hk
2015年論文
@zh-mo
2015年論文
@zh-tw
2015年论文
@wuu
2015年论文
@zh
2015年论文
@zh-cn
name
A pilot study of nimotuzumab p ...... or metastatic cervical cancer.
@ast
A pilot study of nimotuzumab p ...... or metastatic cervical cancer.
@en
type
label
A pilot study of nimotuzumab p ...... or metastatic cervical cancer.
@ast
A pilot study of nimotuzumab p ...... or metastatic cervical cancer.
@en
prefLabel
A pilot study of nimotuzumab p ...... or metastatic cervical cancer.
@ast
A pilot study of nimotuzumab p ...... or metastatic cervical cancer.
@en
P2093
P2860
P1476
A pilot study of nimotuzumab p ...... or metastatic cervical cancer.
@en
P2093
Alfonso Dueñas-González
Blanca Bazán
Eduardo Charco
Horacio Astudillo
Jaime Coronel
Lucely Cetina
Mayra Ramos
Rafael Bojalil
Roberto Jiménez-Lima
Sandra Avila
P2860
P304
P356
10.1080/15384047.2015.1026483
P577
2015-01-01T00:00:00Z